Canadian Journal of Cardiology: Volume 39 (Issue 1 to Issue 12)
The Canadian Journal of Cardiology (CJC) stands as the official journal of the Canadian Cardiovascular Society (CCS) and works in tandem with its companion titles, CJC Open and CJC Pediatric and Congenital Heart Disease. Positioned as a premier venue for Canadian cardiovascular medicine, the CJC serves as a conduit for the global dissemination of groundbreaking knowledge in cardiology and cardiovascular science.
The CJC is dedicated to publishing a diverse range of content, including original reports of clinical and basic research with relevance to cardiovascular medicine. This encompasses editorials, review articles, and case reports, fostering a comprehensive understanding of the field. The journal welcomes contributions on health outcomes, policy research, ethics, medical history, and political issues influencing practice. Letters to the editor are also encouraged, providing a platform for scholarly discourse.
Key features and principles of the CJC include:
- Language and Originality: The CJC exclusively accepts and publishes articles in the English language. Manuscripts are submitted with the understanding that they are exclusive to the Canadian Journal of Cardiology, with no prior publication or consideration elsewhere, except for abstracts. The journal maintains a strict policy against redundant or duplicate publications.
- Authorship and Responsibility: The CCS holds copyright on all published material, emphasizing the importance of responsible authorship. All statements and opinions expressed in the journal are the sole responsibility of the authors. A letter of transmittal accompanying the manuscript signifies that all authors actively participated in the research, reviewed, and concur with the article’s content.
- Open Access Opportunities: Authors are encouraged to explore the open access companion titles, CJC Open and CJC Pediatric and Congenital Heart Disease, providing additional avenues for disseminating research to a broader audience.
In essence, the Canadian Journal of Cardiology remains committed to advancing cardiovascular knowledge and practice on both national and international fronts. Through its diverse content and adherence to rigorous publication standards, the CJC continues to be a vital resource for researchers, clinicians, and practitioners within the realm of cardiovascular medicine.
Volume 39, Issue 1: Pages A1-A10, 1-90 (January 2023)
Theme Issue: Cardiovascular Disease and the Brain
Volume 39, Issue 2, Pages A1-A10, 91-232 (February 2023)
Volume 39, Issue 3: Pages A1-A10, 233-358 (March 2023)
Theme Issue: Recent Advances in Critical Care Cardiology
Volume 39, Issue 4, Pages A1-A16, 359-566 (April 2023)
2023 Canadian Women’s Heart Health Summit Abstract Supplement
2023 Canadian Women’s Heart Health Summit
28-29 April 2023 • Vancouver, British Columbia, Canada
Volume 39, Issue 5, Supplement, Pages A1-A2, S1-S18 (May 2023)
Volume 39, Issue 5: Pages A1-A12, 567-702 (May 2023)
Focus Issue: Advances in Understanding and Managing the Cardiovascular Complications of COVID-19
Volume 39, Issue 6, Pages A1-A8, 703-874 (June 2023)
Volume 39, Issue 7: Pages A1-A10, 875-1020 (July 2023)
Theme Issue: Recent Insights Into the Pathogenesis and Clinical Management of Pericardial Disease
Volume 39, Issue 8, Pages A1-A10, 1021-1158 (August 2023)
Theme Issue: Environmental Determinants of Cardiovascular Disease Pathophysiology and Therapeutics
Volume 39, Issue 9, Pages A1-A8, 1159-1278 (September 2023)
Canadian Cardiovascular Congress 2023
76th Annual Meeting of the Canadian Cardiovascular Society
Vascular 2023
25-29 October 2023 • Montréal, QC
Volume 39, Issue 10, Supplement, Pages A1-A18, S19-S312 (October 2023)
Volume 39, Issue 10: Pages A1-A12, 1279-1482 (October 2023)
Volume 39, Issue 11: Pages A1-A14, 1483-1732 (November 2023)
Focus Issue: Novel Molecular Mechanisms and Therapeutics in Hypertension and Vascular Prevention: Genetics and Beyond
Volume 39, Issue 12, Pages 1733-1994, A1-A10 (December 2023)